Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05058729 · ClinicalTrials.gov registry record
MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study
A clinical trial, sponsored by Biogen.
- Completed
- Registry status
- 1,507
- Enrollment target
NCT05058729 is a clinical trial that has completed, run by Biogen. The registered enrollment target is 1,507 participants.
The verdict
NCT05058729 has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 1,507 participants
- Enrollment target
Study Summary
The primary objective of this sub-study is to supplement the Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) dataset with coronavirus disease 2019 (COVID-19)-related health information obtained from periodic participant questionnaires administered by participating MS PATHS institutions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,507 participants |
| Start Date | 2020-12-07 |
| Est. Completion | 2021-10-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05058729
The ClinicalTrials.gov registry entry for NCT05058729 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,507 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05058729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05058729 about?
NCT05058729 is a clinical study titled "MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study". The primary objective of this sub-study is to supplement the Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) dataset with coronavirus disease 2019 (COVID-19)-related health information obtained from periodic participant questionnaires administered by participating MS...
What is the current status of trial NCT05058729?
This trial is currently completed. The enrollment target is 1,507 participants. The study started on 2020-12-07. Estimated completion is 2021-10-08.
Who is sponsoring clinical trial NCT05058729?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.